Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled alphaVbeta3-integrin and alphaV beta5-integrin imaging agent - Battle, M R; Goggi, J L; Allen, L; Barnett, J; Morrison, M S (J Nucl Med, 2011)